Iron Chelators as Potential Therapeutic Agents for Parkinson's Disease

By  

Current Bioactive Compounds, Vol. 4, Iss. 3, 2008-10 ,pp. : 150-158

Bentham Science Publishers

Access to resources Recommend Favorite

Iron chelators as therapeutic iron depletion agents

By Birch Noah   Wang Xiang   Chong Hyun-Soon  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 11, 2006-11 ,pp. : 1533-1556

Informa Healthcare

Access to resources Recommend Favorite

Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 12, 2014-12 ,pp. : 1125-1140

Bentham Science Publishers

Access to resources Recommend Favorite

Friedreich’s ataxia: iron chelators that target the mitochondrion as a therapeutic strategy?

By Richardson DR  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 235-245

Informa Healthcare

Access to resources Recommend Favorite

The desferrithiocin (DFT) class of iron chelators: potential as antineoplastic agents

By Kicic A.   Chua A.C.G.   Baker E.  

Anti-Cancer Drug Design, Vol. 16, Iss. 4, 2001-08 ,pp. : 195-207

Cognizant Communication Corporation

Access to resources Recommend Favorite